BMA
Overvalued by 98.3% based on the discounted cash flow analysis.
Market cap | $4.58 Billion |
---|---|
Enterprise Value | $-2,160,606,264,190.00 |
Dividend Yield | $3.5422 (3.2202273364486%) |
Earnings per Share | $5090.6 |
Beta | 0.93 |
Outstanding Shares | 63,900,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 16.82 |
---|---|
PEG | -22.69 |
Price to Sales | 0.0 |
Price to Book Ratio | 0.0 |
Enterprise Value to Revenue | -0.44 |
Enterprise Value to EBIT | -7.73 |
Enterprise Value to Net Income | -19 |
Total Debt to Enterprise | -0.28 |
Debt to Equity | 0.15 |
No data
No data